Primary |
Ovarian Cancer |
42.0% |
Premedication |
12.4% |
Product Used For Unknown Indication |
11.9% |
Hypertension |
4.4% |
Infection |
4.4% |
Ovarian Cancer Recurrent |
4.4% |
Ovarian Cancer Metastatic |
3.1% |
Depression |
2.7% |
Adenocarcinoma |
1.8% |
Hypothyroidism |
1.8% |
Prophylaxis Of Nausea And Vomiting |
1.8% |
Sarcoma |
1.8% |
Antiemetic Supportive Care |
1.3% |
Blood Calcium Decreased |
0.9% |
Breast Cancer |
0.9% |
Chemotherapy |
0.9% |
Diabetes Mellitus |
0.9% |
Hypercholesterolaemia |
0.9% |
Leiomyosarcoma |
0.9% |
Neoplasm Malignant |
0.9% |
|
Pancytopenia |
19.0% |
Urinary Tract Infection |
12.1% |
Renal Failure Acute |
10.3% |
Vomiting |
10.3% |
Phlebitis |
6.9% |
Respiratory Failure |
5.2% |
Cognitive Disorder |
3.4% |
Diarrhoea |
3.4% |
Febrile Neutropenia |
3.4% |
Neutrophil Count Decreased |
3.4% |
Palpitations |
3.4% |
Pyrexia |
3.4% |
Rhabdomyolysis |
3.4% |
Acute Myocardial Infarction |
1.7% |
Anaemia |
1.7% |
Aspartate Aminotransferase Increased |
1.7% |
Asthenia |
1.7% |
Atrial Fibrillation |
1.7% |
Cardiac Failure |
1.7% |
Cardiac Failure Congestive |
1.7% |
|
Secondary |
Ovarian Cancer |
29.9% |
Premedication |
15.9% |
Hypertension |
9.2% |
Product Used For Unknown Indication |
5.9% |
Chemotherapy |
5.4% |
Sarcoma |
4.3% |
Depression |
3.8% |
Liposarcoma |
3.5% |
Hypothyroidism |
3.0% |
Adenocarcinoma |
2.2% |
Blood Calcium Decreased |
2.2% |
Diabetes Mellitus |
2.2% |
Hypercholesterolaemia |
2.2% |
Oedema Due To Cardiac Disease |
2.2% |
Platelet Aggregation Inhibition |
2.2% |
Prophylaxis Of Nausea And Vomiting |
1.9% |
Ovarian Cancer Recurrent |
1.3% |
Leiomyosarcoma |
1.1% |
Ovarian Cancer Metastatic |
1.1% |
Antiemetic Supportive Care |
0.8% |
|
Phlebitis |
18.8% |
Pancytopenia |
8.2% |
Vomiting |
8.2% |
Blood Creatine Phosphokinase Increased |
7.1% |
Hypoalbuminaemia |
7.1% |
Neutropenia |
7.1% |
Urinary Tract Infection |
7.1% |
Renal Failure Acute |
5.9% |
Acute Myocardial Infarction |
4.7% |
Cardiac Failure |
4.7% |
Malaise |
3.5% |
Rhabdomyolysis |
3.5% |
Cognitive Disorder |
2.4% |
Diarrhoea |
2.4% |
Neutrophil Count Decreased |
2.4% |
Palpitations |
2.4% |
Aspartate Aminotransferase Increased |
1.2% |
Asthenia |
1.2% |
Cardiac Failure Congestive |
1.2% |
Febrile Neutropenia |
1.2% |
|
Concomitant |
Product Used For Unknown Indication |
36.8% |
Ovarian Cancer |
31.6% |
Synovial Sarcoma |
21.1% |
Breast Cancer Metastatic |
10.5% |
|
Fanconi Syndrome |
25.0% |
Lung Infection |
25.0% |
Sepsis |
25.0% |
Tachycardia |
25.0% |
|